Logo

GoodSense Nicotine Lozenge 4 mg, Reduce Nicotine Cravings and Stop Smoking with a Nicotine Replacement Therapy, 108 Count

FSA/HSA Eligibility

Nicotine replacement therapies, such as GoodSense Nicotine Lozenge 4 mg, are typically eligible for FSA reimbursement as they are considered medical treatments for smoking cessation.

Eligible
Info Icon
The eligibility status is based on Silver’s interpretation of IRS publication 502. FSA/HSA providers might slightly differ in their interpretation, and it’s always recommended to check with your specific provider before assuming an expense will be reimbursed.
GoodSense Nicotine Lozenge 4 mg, Reduce Nicotine Cravings and Stop Smoking with a Nicotine Replacement Therapy, 108 Count

Description

Compare to Nicorette Lozenge active ingredient. Double your chance to successfully quit smoking with GoodSense Nicotine Polacrilex Lozenge, 4 mg (nicotine). GoodSense Nicotine Polacrilex Lozenge, 4 mg (nicotine), Cherry Flavor, is a stop smoking aid for those who smoke their first cigarette within 30 minutes of waking up. This product is part of a Nicotine Replacement Therapy (NRT), designed to wean your body off cigarettes. It helps regulate, control and gradually reduce your body’s nicotine cravings. When used as directed with a support program. Many people require several quit attempts to stop smoking. Quitting smoking doesn’t have to be a daunting task, and with nicotine replacement therapy, you can double your chances of quitting. Perrigo supports the American Cancer Society in their mission to help people quit smoking Perrigo Company pays a fee for the use of the American Cancer Society (ACS) logo. ACS does not endorse any particular brand, service or product.

Do you see any incorrect information on this page? Let us know.

GoodSense Nicotine Lozenge 4 mg, Reduce Nicotine Cravings and Stop Smoking with a Nicotine Replacement Therapy, 108 Count